EUVIMEDEUVIMED entdecken
Open Access

Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis

Preeti Prakash iD, Anoushka Dua, Yair Blumenfeld, Po-Hung Chen iD, Alyssa M Parian, Berkeley N Limketkai

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Preeti Prakash und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Pregnancy Outcome, Pregnancy Complications, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many women with inflammatory bowel disease (IBD) are diagnosed by their reproductive years. Prior literature suggests that women with IBD may be at increased risk of adverse pregnancy outcomes. Biologics have revolutionized IBD treatment, and current evidence favors continuation during pregnancy. We sought to examine trends in pregnancy outcomes over 20 years with the evolution of IBD treatment.

Methods

Using the National Inpatient Sample, IBD and non-IBD obstetric hospitalizations were identified between 1998 and 2018 using International Classification of Diseases 9 and 10 codes. Outcomes of interest included cesarean delivery, gestational diabetes, preeclampsia/eclampsia, premature rupture of membranes (PROM), preterm delivery, fetal growth restriction (FGR), fetal distress, and stillbirth. Stratified by Crohn’s disease (CD), ulcerative colitis (UC), and non-IBD deliveries, temporal trends and multivariable logistic regression were analyzed.

Results

There were 48 986 CD patients, 30 998 UC patients, and 69 963,805 non-IBD patients. Between 1998 and 2018, CD deliveries increased from 3.3 to 12.9 per 10 000 deliveries (P < 0.001) and UC deliveries increased from 2.3 to 8.6 per 10 000 deliveries (P < 0.001). Cesarean deliveries, gestational diabetes, preeclampsia/eclampsia, PROM, FGR, and fetal distress increased over time for IBD and non-IBD women, while preterm deliveries decreased (P < 0.001). Multivariable analyses demonstrated that IBD patients had higher risk of cesarean delivery, preeclampsia/eclampsia, PROM, and preterm delivery compared with non-IBD patients.

Conclusion

Over a 20-year period, live deliveries amongst women with IBD have increased. Trends in pregnancy outcomes have followed a similar trajectory in patients with and without IBD. However, there is still demonstrable risk of adverse pregnancy outcomes in patients with IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomePregnancy ComplicationsInflammatory Bowel DiseasesHumansFemalePregnancyAdultBiological ProductsCrohn DiseaseUnited StatesColitis, UlcerativeYoung AdultCesarean SectionLongitudinal StudiesInfant, NewbornPremature Birth

Stichwörter der Autor:innen

Crohn’s diseaseinflammatory bowel diseasematernal-fetal outcomespregnancyulcerative colitis

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA.
  • Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

ORCID-Profile: Preeti Prakash, Po-Hung Chen

Förderung

  • NIAAA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Prakash, P., Dua, A., Blumenfeld, Y., Chen, P. H., Parian, A. M., & Limketkai, B. N. (2024). Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad250

Vancouver

Prakash P, Dua A, Blumenfeld Y, Chen PH, Parian AM, Limketkai BN. Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad250

BibTeX
@article{Prakash2024,
  author = {Prakash, Preeti and Dua, Anoushka and Blumenfeld, Yair and Chen, Po-Hung and Parian, Alyssa M and Limketkai, Berkeley N},
  title = {Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad250}
}
Kostenlos starten →